Description

Methyl 2-(4-Fluorophenyl)Imidazo[1,2-A]Pyridine-7-Carboxylate is a high-purity, advanced pharmaceutical intermediate belonging to the imidazopyridine class of heterocyclic compounds. This compound is of significant commercial interest for its role as a key building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring targeted molecular structures. It is primarily utilized by research institutions, contract development and manufacturing organizations (CDMOs), and pharmaceutical companies engaged in drug discovery and process development.

Application

• Pharmaceutical Intermediate: Serves as a critical precursor in the multi-step synthesis of potential drug candidates, especially for central nervous system (CNS) and anti-infective therapies.
• Drug Discovery & Medicinal Chemistry: Used extensively in research laboratories for structure-activity relationship (SAR) studies and lead optimization programs due to its imidazopyridine scaffold.
• Process Chemistry & Scale-Up: Employed in the development and optimization of robust, scalable synthetic routes for new chemical entities (NCEs).
• Reference Standard: Supplied as a high-purity analytical standard for method development, quality control, and regulatory submissions.
• Biochemical Research: Utilized as a tool compound for probing biological pathways and enzyme interactions in vitro.

Basic Information

Product Name	Methyl 2-(4-Fluorophenyl)Imidazo[1,2-A]Pyridine-7-Carboxylate
CAS No.	1895711-20-2
Molecular Formula	C15H11FN2O2
Molecular Weight	270.26 g/mol
Synonyms	Methyl 2-(4-fluorophenyl)imidazo[1,2-a]pyridine-7-carboxylate; 7-Carbomethoxy-2-(4-fluorophenyl)imidazo[1,2-a]pyridine; Imidazo[1,2-a]pyridine-7-carboxylic acid, 2-(4-fluorophenyl)-, methyl ester; 2-(4-Fluorophenyl)imidazo[1,2-a]pyridine-7-carboxylic acid methyl ester; Methyl 2-(p-fluorophenyl)imidazo[1,2-a]pyridine-7-carboxylate; 1895711-20-2
EINECS	Contact for details

Quality Control

Our production of Methyl 2-(4-Fluorophenyl)Imidazo[1,2-A]Pyridine-7-Carboxylate adheres to stringent quality management protocols. Every batch is subjected to comprehensive analytical testing, including HPLC, NMR, and MS, to ensure identity, purity, and consistency. We provide detailed Certificates of Analysis (COA) with each shipment, documenting all critical quality attributes. Our quality systems are designed to support regulatory filings and meet the exacting standards required for pharmaceutical R&D and cGMP manufacturing.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). The container should be kept tightly sealed to protect from moisture. For long-term storage, consider storage under an inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (HPLC)	Conforms to reference standard
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.